Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trial

被引:179
作者
Bahadoran, Zahra [2 ]
Tohidi, Maryam [3 ]
Nazeri, Pantea [2 ]
Mehran, Mahya [2 ]
Azizi, Fereidoun [4 ]
Mirmiran, Parvin [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Natl Nutr & Food Technol Res Inst, Dept Clin Nutr & Diet Therapy, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran
关键词
type; 2; diabetes; insulin resistance; broccoli sprouts; sulphoraphane; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; DIETARY;
D O I
10.3109/09637486.2012.665043
中图分类号
TS2 [食品工业];
学科分类号
100403 [营养与食品卫生学];
摘要
Use of antioxidant components is a new approach for improvement of insulin resistance (IR) as a main feature of type 2 diabetes and its complications. The aim of this study was to investigate the effects of broccoli sprouts powder (BSP) containing high concentration of sulphoraphane on IR in type 2 diabetic patients. Eighty-one patients were randomly assigned to receive 10 g/d BSP (A, n = 27), 5 g/d BSP (B, n = 29) and placebo (C, n = 25) for 4 weeks. Fasting serum glucose and insulin concentration, glucose to insulin ratio and homoeostasis model assessment of IR (HOMA-IR) index were measured at baseline and again 4 weeks after treatment. Seventy-two patients completed the study and 63 were included in the analysis. After 4 weeks, consumption of 10 g/d BSP resulted in a significant decrease in serum insulin concentration and HOMA-IR (p = 0.05 for treatment effect). Therefore, broccoli sprouts may improve IR in type 2 diabetic patients.
引用
收藏
页码:767 / 771
页数:5
相关论文
共 21 条
[1]
Azar M., 1980, FOOD COMPOSITION TAB
[2]
Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial [J].
Bahadoran, Z. ;
Mirmiran, P. ;
Hosseinpanah, F. ;
Hedayati, M. ;
Hosseinpour-Niazi, S. ;
Azizi, F. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2011, 65 (08) :972-977
[3]
Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? [J].
Evans, JL ;
Goldfine, ID ;
Maddux, BA ;
Grodsky, GM .
DIABETES, 2003, 52 (01) :1-8
[4]
Evans JL, 2007, INDIAN J MED RES, V125, P355
[5]
Antioxidant functions of sulforaphane: a potent inducer of phase II detoxication enzymes [J].
Fahey, JW ;
Talalay, P .
FOOD AND CHEMICAL TOXICOLOGY, 1999, 37 (9-10) :973-979
[6]
Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease - The San Antonio Heart Study [J].
Hanley, AJG ;
Williams, K ;
Stern, MP ;
Haffner, SM .
DIABETES CARE, 2002, 25 (07) :1177-1184
[7]
Oxidative stress and the etiology of insulin resistance and type 2 diabetes [J].
Henriksen, Erik J. ;
Diamond-Stanic, Maggie K. ;
Marchionne, Elizabeth M. .
FREE RADICAL BIOLOGY AND MEDICINE, 2011, 51 (05) :993-999
[8]
Insulin resistance is a cellular antioxidant defense mechanism [J].
Hoehn, Kyle L. ;
Salmon, Adam B. ;
Hohnen-Behrens, Cordula ;
Turner, Nigel ;
Hoy, Andrew J. ;
Maghzal, Ghassan J. ;
Stocker, Roland ;
Van Remmen, Holly ;
Kraegen, Edward W. ;
Cooney, Greg J. ;
Richardson, Arlan R. ;
James, David E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (42) :17787-17792
[9]
Laakso M, 2001, INT J CLIN PRACT, P8
[10]
Insulin resistance: definition and consequences [J].
Lebovitz, HE .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 :S135-S148